Delivery Order SPE2DR25D1113-SPE2DR26FTC9P
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,118.40 to supply 250 milliliters of Ultane in pen bottle format. The contract, awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, carries firm fixed pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 250 mL of Ultane in a pen bottle configuration, valued at $2,596.98. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by September 12, 2025. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. This delivery order falls under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,012.42 to AmerisourceBergen Drug Corp for the supply of Ultane 250 ML in pen bottle format, with delivery to be completed by December 3, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply chain...
- The Defense Logistics Agency awarded a $1,443.90 delivery order to AmerisourceBergen Drug Corp for 250 ml of Ultane in a pen bottle configuration, with an ultimate completion date of October 17, 2025. This is a firm fixed price, competitively awarded order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ultane 250 ML pen bottles. This firm fixed-price delivery order, valued at $1,299.51, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), an agreement valued at $999.999 billion through December 2026. The contract involves no set-aside designation and was competitively awarded through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Ultane 250 ML in pen bottle format, with a ceiling value of $1,118.40. This is a firm fixed-price delivery order with an ultimate completion date of November 12, 2025, utilizing no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,299.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 250 milliliters of Ultane in pen bottle format, with a completion date of August 22, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and place of performance. The delivery order represents a routine pharmaceutical procurement fulfilling federal medical supply...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Ultane Liquid 250ML, with a firm fixed price ceiling value of $2,816.90 and completion targeted for August 19, 2025. This competitively awarded, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with the Defense Logistics Agency Troop Support Medical, valued at...
- On November 25, 2025, the Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,258.20 to supply Ultane 250 milliliter pen bottles. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The order...
- SPE2DR25D1113Indefinite Delivery Contract
- SPE2DR25D1113-SPE2DR26FTC9PDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,770.80 to AmerisourceBergen Drug Corp for the supply of Ultane 250 ML in pen bottle format. This contract, awarded on November 24, 2025, with an ultimate completion date of November 25, 2025, represents a firm fixed price delivery order with no set-aside designation. The award was competitively solicited and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this prime vendor contract, the company furnishes critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 11/23/25 |